Mirae Asset Global Etfs Holdings Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 111,445 shares of GH stock, worth $7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
111,445
Previous 71,236
56.44%
Holding current value
$7 Million
Previous $3.03 Million
91.13%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$765 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$706 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$313 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$302 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$267 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.42B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...